Related Experiment Video
Updated: Aug 9, 2026

Percutaneous Hepatic Perfusion (PHP) with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver
Published on: July 31, 2016
Fatal arrhythmia following intraoperative continuous hyperthermic peritoneal perfusion chemotherapy
Nien-Chun Chung1, Yen-Chin Liu, Xuan-De Ye
1Department of Anesthesiology, Kaohsiung Veterans General Hospital, School of Medicine, National Yang-Ming University, Taiwan, R.O.C.
Abstract:
Continuous hyperthermic peritoneal perfusion chemotherapy (CHPPC) offers a safe alternative to manage peritoneal tumor seeding in advanced cancer patients. A 65-year-old male underwent exploratory laparotomy for advanced gastric cancer with intraabdominal carcinomatosis and massive ascites. Life-threatening dysrrhythmia of ventricular rhythm with a rate of 120 beats/min developed during the performance of intraoperative CHPPC following eradication of the main tumor. With timely cardiopulmonary resuscitation, appropriate fluid replacement, correction of electrolyte imbalance, and cooling of body temperature, the patient regained effective cardiopulmonary circulation without sequela.

